Related Experiment Video

Updated: May 16, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
10:55

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy

Published on: October 31, 2025

[Anti-SRP myopathy: different entity from myositis]

Shigeaki Suzuki1

  • 1Department of Neurology, Keio University School of Medicine.

Rinsho Shinkeigaku = Clinical Neurology
|December 1, 2012
PubMed

Insights

Anti-signal recognition particle (SRP) myopathy can present as a chronic progressive condition. This subset of patients experiences severe muscle weakness and atrophy, leading to poorer neurological outcomes.

Area of Science:

  • Neurology
  • Immunology
  • Genetics

Context:

  • Anti-signal recognition particle (SRP) antibodies are found in 5-8% of myositis patients.
  • Anti-SRP myopathy is characterized by necrotizing myopathy, distinct from typical myositis.
  • Previous understanding associated anti-SRP antibodies with severe, refractory myositis.

Purpose:

  • To review clinical features of anti-SRP myopathy.
  • To analyze disease progression and neurological outcomes in anti-SRP myopathy patients.
  • To identify distinct clinical phenotypes within anti-SRP myopathy.

Summary:

  • A review of 27 anti-SRP myopathy patients identified a chronic progressive form in 18.5% of cases.
  • This chronic form presents with early-onset muscle weakness and atrophy, and more severe neurological deficits.
  • The study utilized RNA immunoprecipitation assay for anti-SRP antibody detection.

Impact:

  • Highlights a distinct chronic progressive phenotype of anti-SRP myopathy.
  • Suggests that anti-SRP myopathy requires tailored management strategies based on disease course.
  • Contributes to a better understanding of the clinical spectrum and prognosis of anti-SRP myopathy.

Related Concept Videos

Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...